Vinorelbine and mucosal inflammation Patient Reports February 12, 2012

Vinorelbine Side Effects Report #4924569-3
Vinorelbine side effect was reported by a Physician from SPAIN on Feb 10, 2006. Female patient was diagnosed with breast cancer metastatic and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: mucosal inflammation. Vinorelbine dosage: 30 MG/M**2;IV. Patient recovered.

Vinorelbine Side Effects Report #4924589-9
Vinorelbine side effect was reported by a Physician from SPAIN on Feb 10, 2006. Female patient was diagnosed with breast cancer metastatic and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: mucosal inflammation. Vinorelbine dosage: 30 MG/M**2; IV. Patient recovered.

Vinorelbine Side Effects Report #4924686-8
Vinorelbine side effect was reported by a Physician from SPAIN on Feb 10, 2006. Female patient was diagnosed with breast cancer metastatic and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: mucosal inflammation. Vinorelbine dosage: 30 MG/M**2; IV. Patient recovered.

Vinorelbine Side Effects Report #4924694-7
Vinorelbine side effect was reported by a Physician from SPAIN on Feb 10, 2006. Female patient was diagnosed with breast cancer metastatic and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: mucosal inflammation. Vinorelbine dosage: 30 MG/M** 2; IV. Patient recovered.


Vinorelbine Side Effects Report #4924697-2
Vinorelbine side effect was reported by a Physician from SPAIN on Feb 10, 2006. Female patient was diagnosed with breast cancer metastatic and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: mucosal inflammation. Vinorelbine dosage: 30 MG/M**2; IV. Patient recovered.

Vinorelbine Side Effects Report #4948467-4
Vinorelbine side effect was reported by a Physician from SPAIN on Feb 10, 2006. Female patient was diagnosed with breast cancer metastatic and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: mucosal inflammation. Vinorelbine dosage: 30 MG/M**2; IV. During the same period patient was treated with PEGLATED LIPOSOMAL DOXORUBICIN. Patient recovered.

Vinorelbine Side Effects Report #4948476-5
Vinorelbine side effect was reported by a Physician from SPAIN on Feb 10, 2006. Female patient was diagnosed with breast cancer metastatic and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: haematotoxicity, mucosal inflammation. Vinorelbine dosage: 30 MG/M**2; IV. During the same period patient was treated with PEGYLATED LIPOSOMAL DOXORUBICIN. Patient recovered.

Vinorelbine Side Effects Report #4948480-7
Vinorelbine side effect was reported by a Physician from SPAIN on Feb 10, 2006. Female patient was diagnosed with breast cancer metastatic and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: mucosal inflammation. Vinorelbine dosage: 30 MG/M**2; IV. During the same period patient was treated with PEGYLATED LIPOSOMAL DOXORUBICIN. Patient recovered.

Vinorelbine Side Effects Report #4948510-2
Vinorelbine side effect was reported by a Physician from SPAIN on Feb 10, 2006. Female patient was diagnosed with breast cancer metastatic and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: mucosal inflammation. Vinorelbine dosage: 30 MG/M2; IV. During the same period patient was treated with PEGYLATED LIPOSOMAL DOXORUBICIN. Patient recovered.